Reuter James Wealth Management, LLC Amgen Inc Transaction History

Reuter James Wealth Management, LLC

$633 Million
Q4 2025

A detailed history of Reuter James Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Reuter James Wealth Management, LLC holds 3,274 shares of AMGN stock, worth $1.12 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

3,274

Previous 3,782 13.43%

Holding current value

$1.12 Million

Previous $1.07 Million 4.78%

% of portfolio

0.18%

Previous 0.17%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 23, 2026	SELL	$290.13 - $341.71 $147,386 - $173,588	-508 Reduced 13.43%	3,274 $1.12 Million
Q3 2025 Oct 14, 2025	SELL	$271.18 - $309.22 $14,914 - $17,007	-55 Reduced 1.43%	3,782 $1.07 Million
Q2 2025 Jul 24, 2025	BUY	$262.28 - $309.85 $73,962 - $87,377	282 Added 7.93%	3,837 $1.07 Million
Q1 2025 Apr 14, 2025	BUY	$258.59 - $327.36 $144,293 - $182,666	558 Added 18.62%	3,555 $1.11 Million
Q4 2024 Jan 24, 2025	BUY	$258.78 - $328.31 $175,711 - $222,922	679 Added 29.29%	2,997 $781,000

Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $230,797 - $251,685	-746 Reduced 24.35%	2,318 $746,000
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $79,876 - $97,070	304 Added 11.01%	3,064 $957,000
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $54,042 - $65,236	-201 Reduced 6.79%	2,760 $784,000
Q4 2023 Apr 08, 2024	SELL	$255.7 - $288.46 $408,352 - $460,670	-1,597 Reduced 35.04%	2,961 $852,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $42,636 - $52,934	195 Added 4.47%	4,558 $1.23 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $303,406 - $358,771	1,416 Added 48.05%	4,363 $968,000
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $193,727 - $236,121	858 Added 41.07%	2,947 $712,000
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $461,266 - $586,094	-2,014 Reduced 49.09%	2,089 $548,000
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $166,100 - $187,331	740 Added 22.0%	4,103 $925,000
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $3,229 - $3,594	-14 Reduced 0.41%	3,363 $818,000
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $4,823 - $5,336	-22 Reduced 0.65%	3,377 $817,000
Q4 2021 Jan 25, 2022	BUY	$198.88 - $227.6 $675,993 - $773,612	3,399 New	3,399 $765,000

Others Institutions Holding AMGN

# of Institutions

3,319

Shares Held

428M

Call Options Held

6.11M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Reuter James Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reuter James Wealth Management, LLC with notifications on news.

Account

Reuter James Wealth Management, LLC Amgen Inc Transaction History